Congratulations to Prof. Berger and Dr. Saragovi for their article published in e-Life!
In their research, Prof. Berger and Dr. Saragovi used a unique mouse model to examine T-Cell antiviral responses in mice which were kept under low oxygen conditions.
Using molecular, pharmacological, and genetic methods they showed that T-Cell failure to respond under hypoxia stems from mitochondrial biogenesis arrest.
They then demonstrated that hypoxia-arrested T cells in-vivo could be rescued by short exposure to atmospheric oxygen conditions.
Their findings allow for a better understanding of viral infections in hypoxia-associated diseases, and may have clinical implications in the future treatment of such infections.
Congratulations to Prof. Michal Lotem and Dr. Emma Hajaj !
Prof. Lotem and Dr. Hajaj have discovered that two splice variants of the SLAMF6 receptor are found on human T Cells. While one form has a known antagonist role, the other form acts as an agonist that contributes to the anti-tumor response of T Cells.
They show that promoting mRNA splicing, resulting in an elevated expression of the agonistic form as opposed to the antagonistic one, improves human T-Cell capacity to inhibit human melanoma in mice.
This yin-yang relationship of SLAMF6 splice isoforms may represent a balancing mechanism that could be exploited to improve cancer immunotherapy.
Congratulations to Prof. Dana G. Wolf and PhD Student Or Alfi for the recent publication of their novel study in the Journal of Virology !
The researchers reveal SARS-CoV-2 tissue and virus-specific innate immune responses of human nasal-mucosal and lung tissues.
“The study sheds light on the role of the nasal-mucosa in active viral transmission and immune defence, suggesting a window of opportunity for early interventions, in contrast to the restricted innate immune response in early SARS-CoV-2 infected lung tissues which could underlie the unique uncontrolled late phase lung damage of advanced COVID-19.”
Prof. Ofer Mandelboim published a new paper in Nature Communications!
Dr. Einat Seidel led this exiting work into a new role for a human cytomegalovirus derived signal peptide which is slowly cleaved, enabling it to function in immune evasion! Click here to read more about this important and impressive discovery.
Prestigious research grant from the European Research Council for Dr. Yotam Drier
Dr. Yotam Drier was awarded 1.5 million euros from the European Research Council (ERC). The ERC grant will support the Drier lab’s quest to understand epigenetic and topological alterations in cancer and their intratumoral heterogeneity. These efforts include both uncovering fundamental mechanisms that regulate epigenetics and topology, as well as translating these findings to improve treatment of specific cancers, by combining advanced experimental techniques with cutting edge big data analysis. For more information see Dr. Drier’s lab page
Congratulations to Dr. Eliran Kadosh for his exceptional PhD work which was recognized by the International Birnstiel Award!
The International Birnstiel Award for Doctoral Research in Molecular Life Sciences which awards up to 6 PhD students worldwide! This prestigious prize was awarded to Dr. Kadosh for his work published in Nature earlier this year.
Dr. Kadosh conducted his doctoral research in the lab of Prof. Yinon Ben-Neriah, and his hard work led to the discovery of a novel tumor suppressive activity of mutant p53 in the intestine. Excitingly, it was also shown that this activity was impeded by gut bacteria, thus demonstrating the involvement of the microbiome in tumor development.
This prize is a great honor, and we are very proud of Dr. Kadosh’s achievements!
Congratulations to Dr. Oren Parnas and his team on their newest publication in Nature Communications.
Their fascinating and important research applies single cell RNA-seq to uncover important players in the early development of pancreatic cancer, a disease with shockingly low survival rates. For more about their valuable discoveries click here.
Congratulations to Prof. Ben-Neriah and his team on their newest and exciting findings published in Nature!
In the article, Prof. Ben-Neriah and his team show that mutant p53 has an oncogenic effect in the distal gut but a tumor-suppressive effect in the proximal gut, and these opposing properties are determined by the gut microbiome.
Prof. Dov Solizeanou is celebrating his 100th birthday!
Huge mazal tov from the LRC friends and colleagues.
Professor Dov Sulitzeanu, who is one of the founders of the Lautenberg Center and the Department of Immunology is 100 years old and we at the Center give him our warmest greetings and appreciation for building our Center. Dov has been a role model of a scientist for many of his students and colleagues, including group leaders at the Center. Talking to Dov at his birthday I learned that he follows closely the scientific progress of the Center labs and, as always, raises interesting questions and ideas. As such, Dov continues to be a great source of inspiration to the Center’s members and we all wish him many more happy years. Prof. Yinon Ben-Neriah
To our teacher and my long-standing friend Dov, wishing you many years of gratification and fruitful productivity. Prof. Moshe Kotler.
To my rabbi and mentor Dov, I will never forget your dedicated guidance and wisdom as you mentored me throughout my doctoral studies. Prof. David Naor
Congratulations to Prof. Ruth Galili, Orit Berhani, and Amijai Saragovi for receiving the prestigious Kaye Innovation Awards!
Remarkably, three out of the five recipients are members of the Lautenberg Center, and we take pride in their achievements. The Kaye Innovation Awards are given to inventors from the Hebrew University who are solving real-world problems by translating scientific excellence into successful commercial ventures.
Download the Kaye Brochure 2020
Congratulations to Dr. Yotam Drier on receiving a research grant from the Israel Science Foundation (ISF).
The grant will provide support for the next five years for multiple efforts in the Drier lab to systematically uncover how epigenetic alterations drive liver cancers. In addition the ISF will help establish the new Drier lab by supporting advanced experimental equipment and high-end computational infrastructure in a separate new faculty equipment grant.
Prof. Dana Wolf and Dr. Yotam Drier have led efforts to test and implement simple and sensitive pooling approaches to increase the efficiency of clinical testing for SAR-CoV-2.
Thanks to these efforts the throughput of tests of asymptomatic populations at the Hadassah Medical Center increased more than 7-fold, allowing efficient screening of healthcare personnel and nursing homes. This approach can be easily implemented in other clinical labs and drew worldwide attention.
Prof Rami Aqeilan has published a new article article: Pleiotropic tumor suppressor functions of WWOX antagonize metastasis
In the article, Dr. Saleh Khawaled and Prof. Aqeilan show the role of the tumor suppressor WWOXs and its therapeutic potential in antagonize metastasis.
The Aqeilan’s laboratory won the prestigious proof-of-concept ERC (PoC-ERC) grant to develop a cure for WOREE syndrome.
Studying SARS-CoV-2 at the Lautenberg Center
Dr. Oren Parnas and Dr. Yotam Drier collaborate and use their labs’ resources and advanced techniques to study the coronavirus tissue distribution during infection period, and to study the regulation of the human receptor that allows viral entry to cells. These may lead to novel detection and treatment approaches against SARS-CoV-2.